148 related articles for article (PubMed ID: 28901767)
1. 6,7-Seco-ent-Kauranoids Derived from Oridonin as Potential Anticancer Agents.
Xu S; Yao H; Hu M; Li D; Zhu Z; Xie W; Yao H; Wu L; Chen ZS; Xu J
J Nat Prod; 2017 Sep; 80(9):2391-2398. PubMed ID: 28901767
[TBL] [Abstract][Full Text] [Related]
2. A Novel Potent Anticancer Compound Optimized from a Natural Oridonin Scaffold Induces Apoptosis and Cell Cycle Arrest through the Mitochondrial Pathway.
Xu S; Yao H; Luo S; Zhang YK; Yang DH; Li D; Wang G; Hu M; Qiu Y; Wu X; Yao H; Xie W; Chen ZS; Xu J
J Med Chem; 2017 Feb; 60(4):1449-1468. PubMed ID: 28165738
[TBL] [Abstract][Full Text] [Related]
3. The conversion of oridonin to spirolactone-type or enmein-type diterpenoid: synthesis and biological evaluation of ent-6,7-seco-oridonin derivatives as novel potential anticancer agents.
Wang L; Li D; Xu S; Cai H; Yao H; Zhang Y; Jiang J; Xu J
Eur J Med Chem; 2012 Jun; 52():242-50. PubMed ID: 22483090
[TBL] [Abstract][Full Text] [Related]
4. Oridonin derivatives as potential anticancer drug candidates triggering apoptosis through mitochondrial pathway in the liver cancer cells.
Luo D; Yi Y; Peng K; Liu T; Yang J; Liu S; Zhao W; Qu X; Yu W; Gu Y; Wan S
Eur J Med Chem; 2019 Sep; 178():365-379. PubMed ID: 31200238
[TBL] [Abstract][Full Text] [Related]
5. Two cytotoxic 6,7-seco-spiro-lacton-ent-kauranoids from Isodon rubescens.
Luo GY; Deng R; Zhang JJ; Ye JH; Pan LT
J Asian Nat Prod Res; 2018 Mar; 20(3):227-233. PubMed ID: 28436701
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen sulfide donating ent-kaurane and spirolactone-type 6,7-seco-ent-kaurane derivatives: Design, synthesis and antiproliferative properties.
Li H; Gao X; Huang X; Wang X; Xu S; Uchita T; Gao M; Xu J; Hua H; Li D
Eur J Med Chem; 2019 Sep; 178():446-457. PubMed ID: 31202992
[TBL] [Abstract][Full Text] [Related]
7. Enmein-type 6,7-seco-ent-kauranoids from Isodon sculponeatus.
Jiang HY; Wang WG; Zhou M; Wu HY; Zhan R; Li XN; Du X; Li Y; Pu JX; Sun HD
J Nat Prod; 2013 Nov; 76(11):2113-9. PubMed ID: 24219809
[TBL] [Abstract][Full Text] [Related]
8. Novel anticancer oridonin derivatives possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation and nitric oxide release studies.
Xu S; Wang G; Lin Y; Zhang Y; Pei L; Yao H; Hu M; Qiu Y; Huang Z; Zhang Y; Xu J
Bioorg Med Chem Lett; 2016 Jun; 26(12):2795-2800. PubMed ID: 27158140
[TBL] [Abstract][Full Text] [Related]
9. Dimeric ent-kaurane diterpenoids from Isodon excisus.
Hong SS; Lee SA; Lee C; Han XH; Choe S; Kim N; Lee D; Lee CK; Kim Y; Hong JT; Lee MK; Hwang BY
J Nat Prod; 2011 Nov; 74(11):2382-7. PubMed ID: 22066578
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, and evaluation of in vitro and in vivo anticancer activity of 14-substituted oridonin analogs: A novel and potent cell cycle arrest and apoptosis inducer through the p53-MDM2 pathway.
Shen QK; Deng H; Wang SB; Tian YS; Quan ZS
Eur J Med Chem; 2019 Jul; 173():15-31. PubMed ID: 30981113
[TBL] [Abstract][Full Text] [Related]
11. Guidongnins I-J: Two New 6,7-
Zou J; Ye J; Zhao C; Zhang J; Liu Y; Pan L; He K; Zhang H
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686256
[TBL] [Abstract][Full Text] [Related]
12. Novel nitrogen-enriched oridonin analogues with thiazole-fused A-ring: protecting group-free synthesis, enhanced anticancer profile, and improved aqueous solubility.
Ding C; Zhang Y; Chen H; Yang Z; Wild C; Chu L; Liu H; Shen Q; Zhou J
J Med Chem; 2013 Jun; 56(12):5048-58. PubMed ID: 23746196
[TBL] [Abstract][Full Text] [Related]
13. Bioactive enmein-type 6,7-seco-ent-kaurane diterpenoids: natural products, synthetic derivatives and apoptosis related mechanism.
Li H; Sun B; Wang M; Hu X; Gao X; Xu S; Xu Y; Xu J; Hua H; Li D
Arch Pharm Res; 2018 Nov; 41(11):1051-1061. PubMed ID: 30242610
[TBL] [Abstract][Full Text] [Related]
14. Symmetric dimers of ent-kaurane diterpenoids with cytotoxic activity from Croton tonkinensis.
Thuong PT; Pham TH; Le TV; Dao TT; Dang TT; Nguyen QT; Oh WK
Bioorg Med Chem Lett; 2012 Jan; 22(2):1122-4. PubMed ID: 22197145
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic ent-kauranoids from Isodon parvifolius.
Li LM; Li GY; Li SH; Weng ZY; Xiao WL; Han QB; Ding LS; Lou LG; Sun HD
Chem Biodivers; 2006 Sep; 3(9):1031-8. PubMed ID: 17193336
[TBL] [Abstract][Full Text] [Related]
16. Oridonin, a Promising ent-Kaurane Diterpenoid Lead Compound.
Li D; Han T; Liao J; Hu X; Xu S; Tian K; Gu X; Cheng K; Li Z; Hua H; Xu J
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27563888
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic Pathways and Molecular Targets of Plant-Derived Anticancer
Sarwar MS; Xia YX; Liang ZM; Tsang SW; Zhang HJ
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31963204
[TBL] [Abstract][Full Text] [Related]
18. Bioactive Natural Spirolactone-Type 6,7-
Li H; Jiao R; Mu J; Xu S; Li X; Wang X; Li Z; Xu J; Hua H; Li D
Molecules; 2018 Nov; 23(11):. PubMed ID: 30413071
[TBL] [Abstract][Full Text] [Related]
19. Bioactive Enmein-Type ent-Kaurane Diterpenoids from Isodon phyllostachys.
Yang J; Wang WG; Wu HY; Du X; Li XN; Li Y; Pu JX; Sun HD
J Nat Prod; 2016 Jan; 79(1):132-40. PubMed ID: 26757019
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of Oridonin Derivatives via Mizoroki-Heck Reaction and Click Chemistry for Cytotoxic Activity.
Hou W; Fan Q; Su L; Xu H
Anticancer Agents Med Chem; 2019; 19(7):935-947. PubMed ID: 30657049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
